Literature DB >> 9624127

Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron.

H Kishimoto1, S Hoshino, M Ohori, K Kontani, H Nishina, M Suzawa, S Kato, T Katada.   

Abstract

CD38 is a nonlineage-restricted type II transmembrane glycoprotein possessing ecto-NAD+ glycohydrolase activity. Because of its unique expression pattern in lymphocyte differentiation, it appears to function as an immunoregulatory molecule. We previously reported that CD38 was specifically induced by all-trans-retinoic acid (RA) in human promyelocytic leukemia HL-60 cells. Here we studied the molecular mechanism of the RA-dependent induction of human CD38. The expression of CD38 mRNA by RA appeared to be caused by the transcriptional stimulation of the gene, since it was blocked by an RNA synthesis inhibitor, but not by a protein synthesis inhibitor. In search of the RA response element (RARE) possibly present in human CD38 gene promoter, we isolated and sequenced the genomic DNA covering the 5'-flanking region, exon 1, and partial intron 1. Transient transfection experiments revealed that the responsiveness to RA was conferred through an RARE consisting of two direct repeat TGACCT-like hexamer motifs with a 5-nucleotide spacer, which was located in the first intron rather than the 5'-flanking region of the CD38 gene. This RARE interacted with heterodimer composed of RA receptor and retinoid X receptor in vitro. Thus, the RA-induced expression of the human CD38 gene was demonstrated to be mediated through the RARE located in the first intron.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624127     DOI: 10.1074/jbc.273.25.15429

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis.

Authors:  Friedrich Wieser; Juanjuan Wu; Zhaoju Shen; Robert N Taylor; Neil Sidell
Journal:  Fertil Steril       Date:  2012-03-28       Impact factor: 7.329

2.  Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells.

Authors:  Balint L Balint; Attila Szanto; Andras Madi; Uta-Maria Bauer; Petra Gabor; Szilvia Benko; Laszlo G Puskás; Peter J A Davies; Laszlo Nagy
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity.

Authors:  Meisam Naeimi Kararoudi; Yuya Nagai; Ezgi Elmas; Marcelo de Souza Fernandes Pereira; Syed Abbas Ali; Philip Hollingsworth Imus; Darren Wethington; Ivan Marques Borrello; Dean Anthony Lee; Gabriel Ghiaur
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

Review 4.  Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways.

Authors:  Robert N Taylor; Maureen A Kane; Neil Sidell
Journal:  Semin Reprod Med       Date:  2015-07-01       Impact factor: 1.303

5.  Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab.

Authors:  I S Nijhof; R W J Groen; H M Lokhorst; B van Kessel; A C Bloem; J van Velzen; R de Jong-Korlaar; H Yuan; W A Noort; S K Klein; A C M Martens; P Doshi; K Sasser; T Mutis; N W C J van de Donk
Journal:  Leukemia       Date:  2015-05-15       Impact factor: 11.528

Review 6.  The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.

Authors:  Meera E Modi; Larry J Young
Journal:  Horm Behav       Date:  2011-12-20       Impact factor: 3.587

7.  Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cells.

Authors:  Satyaprakash Nayak; Miaoqing Shen; Rodica P Bunaciu; Stephen E Bloom; Jeffrey D Varner; Andrew Yen
Journal:  Leuk Lymphoma       Date:  2010-09

Review 8.  CD38 autoimmunity: recent advances and relevance to human diabetes.

Authors:  A Antonelli; E Ferrannini
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

9.  CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools.

Authors:  Jeffrey P Chmielewski; Sarah C Bowlby; Frances B Wheeler; Lihong Shi; Guangchao Sui; Amanda L Davis; Timothy D Howard; Ralph B D'Agostino; Lance D Miller; S Joseph Sirintrapun; Scott D Cramer; Steven J Kridel
Journal:  Mol Cancer Res       Date:  2018-08-03       Impact factor: 5.852

10.  Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture.

Authors:  Rachid Safi; Garrett G Muramoto; Alice B Salter; Sarah Meadows; Heather Himburg; Lauren Russell; Pamela Daher; Phuong Doan; Mark D Leibowitz; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Mol Endocrinol       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.